IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Casdin Capital, LLC

Q1 2018 Holdings

Filed 2018-05-15 | 31 holdings | $100.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals Inc(AGIO)COM00847X104$29.8M364,77629.8%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$29.8M250,00029.8%
Codexis Inc(CDXS)COM192005106$22.3M2,025,00022.3%
Beigene LTD(ONC)SPONSORED ADR07725L102$11.8M70,00011.8%
Cytomx Therapeutics Inc(CTMX)COM23284F105$5.9M207,5005.9%
Loxo Oncology IncCOM548862101$41.5K360,0000.0%
Foundation Medicine IncCOM350465100$41.0K520,0000.0%
Sage Therapeutics Inc(SG7)COM78667J108$40.3K250,0000.0%
Blueprint Medicines Corp(2L9)COM09627Y109$31.9K348,0000.0%
Spark Therapeutics IncCOM84652J103$30.8K463,0000.0%
Global Blood Therapeutics inCOM37890U108$29.0K600,0000.0%
Myokardia IncCOM62857M105$27.3K560,0000.0%
Sangamo Therapeutics Inc(SGMO)COM800677106$26.6K1,400,0000.0%
Fate Therapeutics Inc(FATE)COM31189P102$25.4K2,600,0000.0%
Bluebird BIO IncCOM09609G100$24.8K145,0000.0%
Voyager Therapeutics Inc(VYGR)COM92915B106$21.3K1,135,0000.0%
Genmark Diagnostics Inc(GNMK)COM372309104$20.9K3,850,0000.0%
Illumina Inc(ILMN)COM452327109$16.9K71,5000.0%
Evolent Health Inc(EVH)CL A30050B101$15.8K1,110,0000.0%
Jounce Therapeutics Inc(JNCEEUR)COM481116101$14.2K635,0000.0%
Audentes Therapeutics Inc(BOLDEUR)COM05070R104$13.5K450,0000.0%
Ishares TR(IBB)NASDAQ BIOTECH464287556$10.1K95,0000.0%
Clovis Oncology Inc(CLVSEUR)COM189464100$9.4K177,5000.0%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$6.2K135,0000.0%
Editas Medicine Inc(EDIT)COM28106W103$4.4K133,3330.0%
Neogen Corp(NEOG)COM640491106$4.4K65,0000.0%
Orasure Technologies Inc(OSUR)COM68554V108$4.1K240,0000.0%
Celgene Corp(CELG)CallCOM151020104$3.6K40,0000.0%
ZAI LAB LTD(ZLAB)ADR98887Q104$2.9K135,0000.0%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$1.7K300,0000.0%
Homology Medicines IncCOM438083107$1.1K60,0000.0%